Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Analysis of risk factors for early death in NPM1-mutated acute myeloid leukemia patients].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 14 Apr 2026

Wang L L, Shu M K, Dou X Q, Ma Y N, Jiang R, Chen H H, Cheng Y X, Chen S N

Abstract excerpt

Objective: To investigate the risk factors for early death (ED) in patients with NPM1-mutated acute myeloid leukemia (NPM1(mut) AML) . Methods: A retrospective analysis was conducted on 405 newly diagnosed primary NPM1(mut) AML patients admitted to the First Affiliated Hospital of Soochow University and the First People's Hospital of Yancheng between June 2018 and June 2023. Clinical and laboratory data at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dioxygenases
Share to DNA-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA (Cytosine-5-)-Methyltransferases

Share to DNA Methyltransferase 3A

Share to fms-Like Tyrosine Kinase 3

Share to Leukemia, Myeloid, Acute

Share to Nuclear Proteins

Share to Nucleophosmin

Source

Open in PubMed Open full text

Identifiers

PMID: 42161659
DOI: 10.3760/cma.j.cn121090-20250929-00452
PMCID: PMC13195547

Genes

NPM1
CD34
FLT3
IDH2
TET2
DNMT3A

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Analysis of risk factors for early death in NPM1-mutated acute myeloid leukemia patients].PMID 42161659Read ↗

ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy.Semantic proximity Read ↗

Vascular complications in NPM1-Mutated acute myeloid leukemia: clinical features and prognosis.Semantic proximity Read ↗

The characteristics and prognostic analysis of therapy-related acute myeloid leukemia patients in China.Semantic proximity Read ↗

Clinical Characteristics, Molecular Analysis and Survival Outcomes of Patients With Extramedullary Acute Myeloid Leukemia: A Retrospective Single-Center Study.Semantic proximity Read ↗

[Clinical characteristics of RUNX1-mutated acute myeloid leukemia patients].Semantic proximity Read ↗

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.Semantic proximity Read ↗

Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.Semantic proximity Read ↗

Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management.Semantic proximity Read ↗

Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-2013.Semantic proximity Read ↗

Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and managementSemantic proximity Read ↗

Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.Semantic proximity Read ↗

[Gene Mutation and Clinical Characteristics of Patients with Acute Leukemia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.